Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2006-11-28
2006-11-28
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S648000
Reexamination Certificate
active
07141696
ABSTRACT:
The present invention relates to smooth muscle spasmolytic agents, pharmaceutical compositions containing them and method of using said compounds and compositions for the treatment of urinary incontinence, and other smooth muscle contractility conditions. More particularly, the present invention relates to certain metabolically stabilized secondary amines having smooth muscle relaxing properties while avoiding, on administration to a mammal, adverse side effects such as prominent antimuscarinic, arrhythmogenic and cardiodepressive effects.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 5236956 (1993-08-01), Sjogren et al.
patent: 5382600 (1995-01-01), Jonsson et al.
patent: 5559269 (1996-09-01), Johansson et al.
patent: 5686464 (1997-11-01), Johansson et al.
patent: 6071970 (2000-06-01), Mueller et al.
patent: 6087346 (2000-07-01), Glennon et al.
patent: 6310103 (2001-10-01), Aberg
patent: 6313132 (2001-11-01), Johansson et al.
patent: 0957073 (1999-11-01), None
patent: 9220377 (1992-11-01), None
patent: 01/36375 (2001-05-01), None
patent: WO03/002059 (2003-01-01), None
Database CAPLUS on STN, Acc. No. 1997:132773, Mueller et al., WO 9640097 (Dec. 19, 1996) (abstract).
Database CAPLUS on STN, Acc. No. 1995:200461, Nemeth et al., WO 9418959 (Sep. 1, 1994) (abstract).
Database CAPLUS on STN, Acc. No. 1977:55074, Gueremy et al., DE 2617486 (Nov. 4, 1976) (abstract).
Database CAPLUS on STN, Acc. No. 1974:433148, Eckhardt et al., Pahlavi Medical Journal (1973), 4(4), p. 461-476.
Database CAPLUS on STN, Acc. No. 1969:96281, Blank et al., Journal of Medicinal Chemistry (1969), 12(2), p. 271-276.
Database CAPLUS on STN, Acc. No. 1970:12330, Cho, US 3468951 (Sep. 23, 1969) (abstract).
Database CAPLUS on STN, Acc. No. 1976:446175, Fujumura et al., JP 51016625 (Feb. 10, 1976) (abstract).
Database CAPLUS on STN, Acc. No. 1975:3960, Fujimura et al., DE 2412798 (Sep. 26, 1974) (abstract).
Database CAPLUS on STN, Acc. No. 1984:448177, Maryanoff et al., Journal of Medicinal Chemistrry (1984), 27(8), p. 1067-1071 (abstract).
Database CAPLUS on STN, Acc. No. 1976:523557, Molloy, DE 2557182 (Jul. 1, 1976) (abstract).
Database CAPLUS on STN, Acc. No. 1981:191089, Giumanini et al., European Journal of Mass Spectrometry in Biochemistry, Medicine and Environmental Research (1980), 1(2), p. 107-116 (abstract).
Database CAPLUS on STN, Acc. No. 1989:533740, Devries et al., Journal of Medicinal Chemistry (1989), 32(10), p. 2318-2325 (abstract).
Database CAPLUS on STN, Acc. No. 1977:21781, Molloy, US 3987201 (Oct. 10, 1976) (abstract).
Database CAPLUS on STN, Acc. No. 2002:575060, Deprez et al., WO 2002059102 (Aug. 1, 2002) (abstract).
Database CAPLUS on STN, Acc. No. 1998:515932, Miyachi et al., Bioorganic & Medicinal Chemistry Letters (1998), 8(14), p. 1807-1812 (abstract).
Database CAPLUS on STN, Acc. No. 1962:455898, Easton et al., Journal of Organic Chemistry (1962), 27, p. 2746-2748 (abstract).
Database CAPLUS on STN, Acc. No. 1977:21781, Molloy, US 3987201 (Oct. 19, 1976) (abstract).
Database CAPLUS on STN, Acc. No. 1977:534477, Molloy, US 4034011 (Jul. 5, 1977) (abstract).
Database CAPLUS on STN, Acc. No. 2003:30086, Zhou et al., Zhongguo Yaowu Huaxue Zazhi (2002), 12(3), p. 138-140 (abstract).
Database CAPLUS on STN, Acc. No. 1998:682217, Johansson et al., WO9843942, Oct. 8, 1998 (abstract).
Acta Physiol. Scand. 1965. 64. 15-27; A.K. G. Aberg et al. ;“Some Mechanical Aspects of an Intestinal Smooth Muscle”.
J.Org. Chem. 1998, 63; 8067-8070; Andersson et al.; “Asymmetric Total Synthesis of (+)-Tolterodine, a New Muscarinic Receptor Antagonist, via Copper-Assisted Asymmetric Conjugate Addition of Aryl Grignard Reagents to 3-Phenyl-prop-2-enoyl-oxazolidinones”.
Drug Metabolism and Disposition 1998, 26: 528-535; Andersson et al.; “Biotransformation of Tolterodine, a New Muscarinic Receptor Antagonist, in Mice, Rates and Dogs”.
International Journal of Chemical Pharmacology and Therapeutics, vol. 35 No. 7—1997 (287-295); Brynne et a.; “Pharmacokinetics and pharmacodynamics of tolterodines in man: a new drug for the treatment of urinary bladder overactivity”.
J. Urol. 1997, 157: Gillberg, P-G et al; Pharmacological profile of DD01 and desethyloxybutynin (DEOB)-the major metabolite of tolterodine and oxybutynin ABSTRACT 312.
J. Org. Chem. 1993, 58, 766-770; Nicolas et al.; “Asymmetric 1,4-Addition of Organocuprates to Chiral α,β-Unsaturated N-Acyl-4-phenyl-2-oxazolidinones: A New Approach to the Synthesis of Chiral β-Branched CarboyxlicAcids”.
Pharmacology & Toxicology 1997, 81, 169-172; Lisbeth Nilvebrant et al.; “Antimuscarinic Potency and Bladder Selectivity of PNU-200577, a Major Metabolite of Tolterodine”.
Drug Metab Dispos, 26(4) 289-93 1998 Abstract; Postlind H, et al.; “Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes”.
Arzneim-Forsch./Drug Res. 48 (II), 10, 1012-1018 (1989); Emil R. Smith et al.; “Comparison of the Antimuscarinic and Antispasmodic Actions of Racemic Oxybutynin and Desethyloxybutynin and Their Enantiomers with Those of Racemic Terodiline”.
Journal of Neurochemistry vol. 32, pp. 1653-1663; Chang et al.; “Heterogeneity of Histamine H1-Receptors: Species Variations in [3H] Mephyramine Binding of Brain Membranes”.
Copy of the International Search Report dated Dec. 1, 2004.
Aberg A. K. Gunnar
Chen Jan L.
Maioli Andrew T.
Wright George E.
Bridge Pharma, Inc.
Davis Brian
Nields & Lemack
LandOfFree
Smooth muscle spasmolytic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Smooth muscle spasmolytic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Smooth muscle spasmolytic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3658277